Skip to content

Evaluation of the effects on blood glucose level: a randomized, double-blind, crossover trial

Evaluation of the effects on blood glucose level: a randomized, double-blind, crossover trial - Evaluation of the effects on blood glucose level

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030701
Enrollment
10
Registered
2019-03-16
Start date
2018-01-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese adult people

Interventions

Duration: single dose Test material: Test food 1, Test food 2 Administration: Eat six of each test food without chewing in 20 minutes at the examination &lt
[1] Eat Test food 1 [2] Washout period is for more than a day. [3] Eat Test food 2 Duration: same as above Test material: same as above Administration: same as above &lt
[1] Eat Test food 2 [2] Washout period is for more than a day. [3] Eat Test food 1

Sponsors

ORTHOMEDICO Inc.
Lead Sponsor
Medical Corporation Seishinkai, Takara Clinic
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy Japanese adult people 2. Subjects who are judged as eligible to participate in the study by the physician 3. Within the subjects who met 2nd inclusion criteria, select subjects with relatively few blood test results, which are out of the reference values at screening

Exclusion criteria

Exclusion criteria: 1. At least one previous medical history of malignant tumor, heart failure or myocardial infarction 2. Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases 3. Subjects who have dysphagia 4. Subjects who use or take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily 5. Currently taking medicines (include herbal medicines) and supplements 6. Subjects who are allergic to medicines and/or the test food related products. Particularly allergic to corn, orange, and soybean. 7. Subjects who are pregnant, breast-feeding, and planning to become pregnant 8. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial 9. Subjects who are judged as ineligible to participate in the study by the physician

Design outcomes

Primary

MeasureTime frame
Blood glucose level * Assess before eating the test food and at 30, 60, 90, and 120 minutes after eating the test food. * Assess the area under curve (AUC) between before eating the test food and 120 minutes after eating the test food, the maximum blood concentration (Cmax), and the blood glucose level of each measuring point.

Countries

Japan

Contacts

Public ContactNaoko SUZUKI

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026